Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
Management of Acne in Teens
An Update on Heart Failure in General Practice
Invasive Pneumococcal Disease – What GPs Need to Know
Innovations in Breast Radiation
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis